Investor Presentation

Seed Innovations

11/02/2026 07:00

RNS Number : 4859S

Seed Innovations Limited

11 February 2026

 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

REACH Announcement

 

11 February 2026

SEED Innovations Ltd

("SEED" or the "Company")

 

Investor Presentation Notification

 

Introduction to Recently Appointed Directors & New Investing Strategy

 

SEED Innovations Ltd, the AIM-quoted investing company, is pleased to announce that it will host an investor presentation on 26 February at 12.00 pm via the Investor Meet Company platform.

 

The presentation will introduce the Company's directors, being Jim Mellon, Denham Eke, Sir James Bucknall, Lance de Jersey and Luke Cairns. Bob MacDonald, who leads Hoid.ai and has been appointed to support SEED's new investing strategy, will also present an overview of the strategy, which is focused on high-growth robotics and artificial intelligence ventures.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9:00am GMT on 25 February.

 

Shareholders who wish to attend or ask questions should register in advance using the following link:

https://www.investormeetcompany.com/seed-innovations-limited/register-investor

 

Investors who already follow SEED Innovations Ltd on the Investor Meet Company platform will receive an automatic invitation.

 

- Ends -

 

For further information, visit: www.seedinnovations.co or contact: 

 

Lance de Jersey
SEED Innovations Ltd
E:info@seedinnovations.co
James Biddle
Roland Cornish
BeaumontCornishLimited
Nomad
T: (0)20 7628 3396
Isabella Pierre
Damon Heath
Shard Capital Partners LLP
Broker
T: (0)20 7186 9927
Ana Ribeiro
Isabel de Salis
St Brides Partners Ltd
Financial PR
E: seed@stbridespartners.co.uk

 

NOTES 

Seed Innovations Ltd 

SEED Innovations Ltd (SEED.L) is an AIM-quoted investment company focused on providing access to high-growth robotics and AI ventures typically beyond the reach of everyday investors. The Company also oversees a legacy portfolio in wellness and life sciences, with a medium-term strategy to unlock its full value. Back by an experienced team and strong cash reserves, the Company remains agile and well-positioned to capitalise on new investment opportunities as they arise.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
NRAAKKBDOBKDQBD